Patent directory · USPTO A61K / A61P
Patents matching “Neurocrine Biosciences, Inc.”
110 pharma patents match "Neurocrine Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 110 pharmaceutical patents matching "Neurocrine Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6469166
Thiophenopyrimidines
expired -
US 6440960
CRF receptor antagonists and methods relating thereto
expired -
US 6384221
Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
expired -
US 6379670
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
expired -
US 6369033
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
expired -
US 6348466
CRF receptor antagonists and methods relating thereto
expired -
US 6329499
Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
expired -
US 6288060
Amino substituted pyrimidines and triazines
expired -
US 6255310
Thiophenopyrimidines
expired -
US 6251396
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
expired -
US 6239268
Interleukin-1 type 3 receptors
expired -
US 6211195
CRF antagonistic thiophenopyridines
expired -
US 6197926
Methods for treatment of diabetes using peptide analogues of insulin
expired -
US 6133276
Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
expired